T ELOMERES, THE DNA-PROTEIN complexes at the end regions of chromosomes,decreaseinlength with every cell division.
T ELOMERES, THE DNA-PROTEIN complexes at the end regions of chromosomes,decreaseinlength with every cell division. 1 In primary blood cells, telomeres are partly reconstructed by the activity of telomerase, a specialized intracellular enzyme that adds subunit repeats to telomeres. 2 Despite the activity of telomerase, telomeres continue to shorten with repeated cell divisions, leading to disrupted cell function and eventual cell senescence. 3, 4 Telomere shortening in leukocytes has implications for immunocompetence [1] [2] [3] [4] and is associated with increased synthesis of proinflammatory cytokines and poorer antibody response to vaccines. [5] [6] [7] Shorter leukocyte telomere length also is associated with aging-related morbidity and mortality from conditions with immune system involvement, including infectious diseases, 8, 9 cancer, 10 and cardiovascular disease. 11 The rate of progression to senescence differs among lymphocyte subsets, with an advanced rate of telomere shortening in the cytolytic CD8 T cells. 12 This is especially important for cancer and virally induced infectious diseases, because rapid loss of telomere length in cytolytic Importance Although leukocyte telomere length is associated with mortality and many chronic diseases thought to be manifestations of age-related functional decline, it is not known whether it relates to acute disease in younger healthy populations.
Objective To determine whether shorter telomeres in leukocytes, especially CD8CD28Ϫ T cells, are associated with decreased resistance to upper respiratory infection and clinical illness in young to midlife adults.
Design, Setting, and Participants Between 2008 and 2011, telomere length was assessed in peripheral blood mononuclear cells (PBMCs) and T-cell subsets (CD4, CD8CD28ϩ, CD8CD28Ϫ) from 152 healthy 18-to 55-year-old residents of Pittsburgh, Pennsylvania. Participants were subsequently quarantined (single rooms), administered nasal drops containing a common cold virus (rhinovirus 39), and monitored for 5 days for development of infection and clinical illness.
Main Outcome Measures Infection (virus shedding or 4-fold increase in virusspecific antibody titer) and clinical illness (verified infection plus objective signs of illness).
Results Rates of infections and clinical illness were 69% (n=105) and 22% (n=33), respectively. Shorter telomeres were associated with greater odds of infection, independent of prechallenge virus-specific antibody, demographics, contraceptive use, season, and body mass index (PBMC: odds ratio [ 
Conclusion and Relevance
In this preliminary study among a cohort of healthy 18-to 55-year-olds, shorter CD8CD28Ϫ T-cell telomere length was associated with increased risk for experimentally induced acute upper respiratory infection and clinical illness. CD8Tcellscausescellsenescencemarked bylossofexpressionofCD28, 13 acostimulatory molecule important for antiviral function.
In this study we assessed whether telomere length in leukocytes is associated with host resistance to experimentally induced viral upper respiratory infection in young to midlife adults. Our expectation was that shorter leukocyte telomere length, especially in CD8CD28Ϫ cells, would be associated with an increased risk for infection and clinical illness.
METHODS

Participants
Participants were 152 healthy residents of the greater Pittsburgh, Pennsylvania, area aged 18 through 55 years and recruited by newspaper advertisements to participate in a study of the causes of the common cold. Each received $1000 for participating in the study. The study received approval from the Carnegie Mellon University and University of Pittsburgh human participants review boards, and all participants provided signed informed consent.
Design
Healthy participants who had their blood drawn for telomere assessment were subsequently quarantined, administered nasal drops containing a rhinovirus that causes the common cold (rhinovirus type 39 [RV39]), and monitored for 5 days for development of infection and clinical illness.
Data were collected between 2008 and 2011. Volunteers were screened 6 to 8 weeks before viral administration and enrolled only if they reported no acute or chronic illnesses; were in good health as assessed by a complete physical examination that included examination of the ear, nose, and throat, complete blood and urine panels, and human immunodeficiency virus testing; did not take prescription medications, with the exception of birth control; and had specific neutralizing serum antibody titers to the experimental rhinovirus of 4 or less. Participants were later excluded from the study if they reported to quarantine with symptoms or signs of illness, had rhinovirus isolated in their nasal lavage fluid on that day, tested positive for pregnancy on that day, or had a nonchallenge strain of rhinovirus isolated during cloister.
During the period before viral challenge, data on 7 control variables (covariates) were collected to exclude potential alternative explanations for associations between telomere length and infections or colds: prechallenge viral-specific antibody titer (day before challenge), body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared), sex/birth control use (men, womentakingcontraceptives,womennot taking contraceptives), season of exposure (spring, summer, winter), number of days before viral challenge that blood for telomere length assay was drawn, and self-reportedage(years)andrace(selected fromwhite,black,NativeAmerican,Asian/ PacificIslander,Hispanic/Latino,orother). Because of small numbers of participants endorsing nonblack minority racial categories, race was recoded into a dichotomous variable (white=0, other=1) for analyses.
Bloodforassessmentoftelomerelength was collected, processed by cell separation,andstoredforlaterassay.Participants were then quarantined in a local hotel for 6 days. After the first 24 hours of quarantine (quarantine day 0), participants received nasal drops containing 100 tissue culture infectious doses of RV39. Daily throughout quarantine, nasal lavage samples were collected for isolation of the challenge virus and participants were evaluatedforobjectivesignsofillness.Following approximately 28 days after exposure to the virus, blood samples were taken for assay of convalescent serumspecific antibody titer to the challenge virus.Investigatorsconductingthetelomere length assays, which were performed in batch after all trials were concluded, were blinded to all participant data.
Procedures of the Viral Challenge Trial
Infection. Infection was defined as isolation of the challenge virus in nasal secretions (cultured using standard procedures 14 ) on any of the postexposure quarantine days or as a 4-fold or greater increase in specific antibody titer to the challenge virus (microtiter neutralization assay 15 ) from before to 28 days after exposure.
Clinical Illness. Individuals were considered to have a cold on meeting the criteria for both infection and objective signs of illness. Objective signs of illness were assessed using 2 daily measures: nasal mucociliary clearance time and mucus weight. Nasal mucociliary clearance time-an indicator of nasal congestion-was measured as the time (seconds) needed for a flavored dye administered to the inferior turbinates to arrive at the nasopharynx. 16 Mucus weight (grams)-a marker of nasal secretion production-was measured by weighing sealed plastic bags containing the participants' used paper tissues and then subtracting the weights of unused tissues and empty plastic bags. 16 These measures were calculated on a daily basis with all daily measures adjusted for baseline by subtracting baseline values (mode values, 0 seconds and 0 g) from the daily values. Negative adjusted values were given a score of 0. The criterion for illness was a total (sum of 5 days) adjusted weight of mucus of 10 g or greater or an average adjusted time of nasal mucociliary clearance of 420 seconds (7 minutes) or longer.
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Telomere Length. Because we could not conduct timely cell separations and preservation for the entire sample in a single day, whole blood for telomere length assay was collected from a random one-third of participants on each of 3 days: during the baseline screening visit (6-8 weeks prequarantine), 3 to 5 days prequarantine, or on the baseline day of quarantine. Blood samples were collected by standard venipuncture into 3 green-top (heparinized) collection tubes. Lymphocyte subsets from each blood sample were labeled with fluorochrome conjugated mouse antihuman monoclonal antibodies (BD Bioscience Pharmingen) in RosetteSep cocktails, isolated immediately using an automated immunomagnetic cell separator (RoboSep, StemCell Technologies), and then stored at Ϫ80ЊC.
Total DNA was purified from each cell subset, including peripheral blood mononuclear cells (PBMCs) and CD4, CD8CD28ϩ, and CD8CD28Ϫ cells (DNeasy Blood & Tissue Kit, Qiagen). Duplicate DNA samples (20 ng) from each cell subpopulation were amplified using primers of telomere (forward, 5'-CGGTTT[GTTTGG] 5 GTT-3'; reverse, 5'-GGCTTG[CCTTAC] 5 CCT-3') and a single copy gene (36B4; forward, 5'-CAGCAAGTGGGAAGGTGTAATCC-3'; reverse, 5'-CCCATTCTATCATCAAC-GGGTACAA-3'), separately, on the same plate in 1ϫ SYBR Green master mix (Applied Biosystems) using a real-time quantitative polymerase chain reaction assay (qRT-PCR) (7300 Fast Real Time PCR system, Applied Biosystems) as per a published protocol. 18 Applied Biosystems SDS software was used to generate standard curves and to determine the dilution factors of standards corresponding to the telomere (T) and single-copy gene (S) amounts in each sample. From these data, a T:S ratio was computed, providing an index of average telomere length. Coefficients of variation were 12% and 13% for T and S, respectively. In a subsample of 26 participants, qRT-PCRderived T:S ratio was correlated (r=0.64, PϽ.001) with telomere length as determined by terminal restriction fragment Southern blot analysis.
Although the blood volumes used for telomere assays were the same across cell types, samples differed randomly in cell number and thus in DNA concentration. This, in combination with random cell loss during separation and DNA purification, resulted in some samples containing insufficient DNA for telomere assay.
Statistical Analyses
Pearsoncorrelations(randPvalues)were used to assess associations between continuous variables, analysis of variance (F and P values) to test differences in telomere length among categorical control variables, and paired (within-person) t tests (t and P values) to compare telomere length differences between cell types. We used multiple logistic regression 19 to predict the binary outcomes, incidence of infection, and clinical illness. All regression equationsincludedthe7controlvariables (covariates) described in the design section. Telomere length (T:S ratio) was normally distributed in all cell populations andforanalysiswasstandardized(zscore) and treated as a continuous variable. Shorter telomere length could be related to risk for clinical colds through an association with either increased risk of infection among all participants, increased risk of developing clinical illness among participantswhobecameinfected,orboth. We tested the second hypothesis by conducting a multiple logistic regression (includingallstandardcovariates)withclinical illness as the outcome and using data only from the subset of participants who became infected with the challenge virus. Interaction terms were entered in separate analyses including the covariates and relevant main effects.
For all main effects of the logistic regressions we report odds ratios (ORs) and 95% CIs. To facilitate interpretation, we present inverse ORs, which indicate the change in the odds of developing an infection or cold with each 1-SD decrease in standardized telomere length. Interactions are reported as unstandardized logistic regression coefficients (b), with 95% CIs and P levels. Likelihood ratio tests are used to compare models. As a result of the high prevalence of infection and colds, the ORs presented herein should not be interpreted as risk ratios. Consequently, we also transformed ORs to relative risks for significant associations 20 using the longest quartile of telomere length as the unexposed value. 21 Power for this study was estimated at 80% based on an expected OR of 2.0 for each 1-SD decrease in telomere length, 2-tailed tests with PϽ.05, and an N of 125 or greater. All statistics were performed using IBM SPSS Statistics version 20 (SPSS Inc). All tests were 2-tailed. Older age was correlated with shorter telomere length in PBMCs (n = 128, r = Ϫ0.17, P = .05), CD8CD28ϩ cells . When telomere length from all 3 subsets were simultaneously examined in the same regression (PBMC telomere length was not included in this analysis because that mixed population includes the other 3 cell types), we found that CD8CD28Ϫ telomere length was the only one of the 3 measures to enter the equation. That is, CD8CD28Ϫ telomere length had the strongest association with infection, and once it was included in the model, telomere length in the remaining cell types did not improve the prediction.
RESULTS
Sample Characteristics
Telomere Length and Clinical Illness (Colds). Twenty-two percent of the entire sample (n=33) developed a clinical illness (common cold). As shown in Table 3 and Figure 1 , only telomere length in the CD8CD28Ϫ subset was associated with risk for clinical illness, with shorter telomeres being associated with greater risk.
Pathways Linking CD8CD28؊ Telomere Length to Clinical Illness. In the analysis testing whether telomere length is associated with the development of signs of illness among infected individuals, limited to the participants who were infected (n=97), there was no association between telomere length and colds (OR, 1.11 [95% CI, 0.59-2.07]).
Telomere Length, Infection, and Clinical IIlness, by Age. We tested whether the magnitude of the association of CD8CD28Ϫ telomere length with infection and clinical illness varied across age. The magnitude of the association between telomere length and infection increased with increasing age (interaction, b=0.09 [95% CI, 0.02-0.16], P=.01, Abbreviations: OR, odds ratio; PBMC, peripheral blood mononuclear cell; RR, relative risk; T:S, ratio of telomere to single-copy gene amounts. a Ratio of telomere to single-copy gene amounts (T:S ratio) used as an index of average telomere length. All logistic regression models were adjusted for prechallenge viral-specific antibody titer, age, body mass index, race, sex/ contraceptive use (men, women taking contraceptives, women not taking contraceptives), season of exposure, and days between blood draw for telomere assay and viral challenge. Each association was generated from an equation including telomere length in only the 1 cell type. ORs are standardized to indicate change in odds of infection or clinical illness with each 1-SD decrease in telomere length. ORs were converted to RRs using the formula of Zhang and Yu 20 and approximating the incidence of the outcome in the unexposed group to be equivalent to the incidence among the longest quartile of telomere length for each relevant cell type. b Ns differ between cell types owing to insufficient DNA content in some blood samples. Analyses involving each cell population were conducted with data only from those participants with complete telomere length data for that cell type. c R 2 =Nagelkerke pseudo-R 2 for fully adjusted model (ie, telomere lengthϩcovariates); ⌬R 2 =absolute change in Nagelkerke pseudo-R 2 after addition of telomere length to model including covariates only. d Likelihood ratio test comparing the fully adjusted model including all covariates and telomere length with the model including covariates only.
n=144; 2 1 =9.12 by likelihood ratio test, P=.003). To facilitate the interpretation of the interaction, ORs for separate analyses of each age tertile are presented in FIGURE 2. For colds, the form of the interaction was similar to that of infection but did not reach statistical significance, and addition of the interaction term did not significantly improve the model fit (b=0.05 [95% CI, Ϫ0.001 to 0.10], P =.09; 2 1 =3.16 by likelihood ratio test, P = .08).
COMMENT
Leukocyte telomere length has emerged as a predictor of earlier onset of agingrelated morbidity and mortality in older adults. [8] [9] [10] [11] Telomere length traditionally has been thought important in agerelated functional decline and development of chronic disease. No studies have examined whether shorter telomere length might also be related to acute functional consequences in younger, healthy populations. In this study, we used a prospective viral-challenge methodology to test whether leukocyte telomere length is associated with host resistance to standardized exposure to a virus that causes the common cold in humans (RV39). Further, because CD8CD28Ϫ T cells appear to play an important role in immune response to immunization and are particularly prone to early telomere shortening, we compared telomere length in these cells with length in several other peripheral blood cell populations.
We found that shorter telomere lengths in all 4 cell types were associated with greater odds of infection following experimental exposure to RV39. However, CD8CD28Ϫ telomere length had the largest association with infection. Moreover, after CD8CD28Ϫ telomere length was entered into the logistic equation, adding the telomere length for other cell types did not improve the prediction. Further, only CD8CD28Ϫ telomere length was associated with clinical illness.
When examining these relations by age, we found that the association between CD8CD28Ϫ telomere length and infection increased with increasing age. The increasing importance of leukocyte telomere length with advancing age may be attributable to cells with very short telomeres becoming more prevalent as individuals get older (eg, 31% of 30-to 55-year-olds vs 17% of 18-to 22-yearolds had CD8CD28Ϫ telomere lengths in the bottom 20% of the distribution); to a younger immune system more effectively compensating for the level of CD8 cell senescence; or to Ratio of telomere to single-copy gene amounts (T:S ratio) used as an index of average telomere length. Total Ns differ between cell types owing to insufficient DNA content in some blood samples. Data for each cell population are presented based on data from only those participants with complete telomere length data for that cell type. Y-axis segments in blue indicate range y=0 to y=30.
CD8 cell senescence contributing to immune impairment, especially impairment occurring within the context of other age-related biological changes. This is a preliminary study with a small volunteer sample and modest effect sizes. However, because these analyses were prospective, we can eliminate reverse causation (developing an infection or illness in this study did not cause shortening of telomere length) as an alternative explanation. Use of multiple control variables (age, sex/birth control status, race, prechallenge antibody, season, BMI, day of blood draw to assess telomere length) eliminated many potential spurious explanations. Even so, the possibility remains that alternative unspecified third variables, eg, a common genetic contributor to both telomere length and susceptibility to infection, could account for our results. Also, the generalizability of the results may be limited if study volunteers differ significantly from the wider population.
There are no published functional data (eg, differences in virusstimulated proliferation or cytokine production) comparing CD8CD28ϩ and CD8CD28Ϫ cells as they pertain specifically to rhinovirus infection. Consequently, the explanations for our findings are speculative and based on a more general understanding of the function of these cells. Because CD8 lymphocytes are important for eliminating virus-infected cells, a decreased ability to replicate would likely contribute to an increased susceptibility to viral infection. CD8CD28Ϫ cells with short telomeres are near or have already reached replicative senescence 2 2 and have poor antigeninduced proliferation. 23 Thus, the number of effector cells available to respond to the virus may be reduced in persons with a large number of senescent or near-senescent CD8 cells.
There is a close relationship between the CD28 molecule and the telomere/telomerase aging system. 18, 24 Without CD28, cells can no longer upregulate telomerase during activation, which is essential for proliferation, cytokine/chemokine production, and antiviral activity. 22 Maintaining CD28 (through gene transduction) slows immunosenescence by increasing telomerase activity and cell proliferation and by reducing proinflammatory cytokine expression in vitro. 25 Given these in vitro findings, it is reasonable to expect that in vivo loss of CD28 from CD8 cells should impair the host's ability to fight infection.
Previous research has shown telomere length to be shorter in CD8CD28Ϫ cells relative to CD8CD28ϩ cells, with that research being restricted to samples of patients who are older 26 or human immunodeficiency virus-positive 27 and to 1 small study (N=10) of 29-to 59-yearolds. 28 In contrast, we found no difference in telomere length between CD8CD28Ϫ and CD8CD28ϩ cells in our healthy younger sample (mean age, 29.9 years). Nevertheless, CD8CD28Ϫ cells did show a wide range of telomere lengths.
In sum, this study found an association between leukocyte telomere length and resistance to a common virus infection in healthy young and midlife adults. These findings are consistent with the wide variance in leukocyte telomere length found in young adults. 18 The presence of short telomeres among young people could result from several factors including genetics, 2 9 , 3 0 older paternal age at conception, 26 poor health behaviors, and oxidative 31 and chronic psychological stress. 32, 33 CD8 cell senescence has also been attributed to the presence of latent viral infections 34, 35 and proinflammatory environments. 36 Implicit in the relationship between telomere length and colds in this study is that telomere length is relatively stable over the course of at least 1 to 2 months. Published data from a small study of 30-to 50-year-olds found that telomere length in leukocytes is quite stable over the course of 7 months (r = 0.93), 37 whereas a 10-year follow-up of a large sample of older adults (Ͼ53 years) found a still substantial but smaller association (r = 0.65). 38 Evidence of long-term stability is also suggested by correlations of telomere length with stable individual characteristics including genetic markers, 29, 30 education, 39 and stable psychological dispositions. 40, 41 A provocative possibility is that telomere length is a very stable marker of disease susceptibility, with associations between telomere length and clinical outcomes beginning to emerge in early adulthood.
In this study of healthy young and midlife adults, shorter CD8CD28Ϫ cell telomere length was associated with upper respiratory tract infection and clinical illness following experimental exposure to rhinovirus. Because these data are preliminary, their clinical implications are unknown. Ratio of telomere to single-copy gene amounts (T:S ratio) used as an index of average telomere length. Age is presented in tertiles in the figure to facilitate interpretation. Error bars indicate 95% CIs. Odds ratios (ORs) can be interpreted as the increase in the odds of infection with each 1-SD decrease in telomere length. Each age group was analyzed in a separate logistic regression analysis that included the following control variables: prechallenge viral-specific antibody titer, body mass index, age, race, sex/contraceptive use (men, women taking contraceptives, women not taking contraceptives), season of exposure, and days between blood draw for telomere assay and viral challenge. Conversion of ORs to relative risks (RRs) using the formula of Zhang and Yu 20 and setting the infection rate for the unexposed group equal to that of the quartile of longest CD8CD28Ϫ telomere length (ie, 50%) yields RR, 0.75 (95% CI, 0.25-1.49) for 18-to 22-yearolds; RR, 1.65 (95% CI, 1.13-1.91) for 23-to 29-year-olds; and RR, 1.76 (95% CI, 1.21-2.04) for 30-to 55-year-olds.
